427 related articles for article (PubMed ID: 25034284)
21. [Progress on role of extracellular ATP and its metabolite adenosine in immunoregulation: Review].
Wang C; Yin Q; Su Z; Xia L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1134-1140. PubMed ID: 33325366
[TBL] [Abstract][Full Text] [Related]
22. Extracellular purines, purinergic receptors and tumor growth.
Di Virgilio F; Adinolfi E
Oncogene; 2017 Jan; 36(3):293-303. PubMed ID: 27321181
[TBL] [Abstract][Full Text] [Related]
23. Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null mice.
Sun X; Han L; Seth P; Bian S; Li L; Csizmadia E; Junger WG; Schmelzle M; Usheva A; Tapper EB; Baffy G; Sukhatme VP; Wu Y; Robson SC
Hepatology; 2013 Jan; 57(1):205-16. PubMed ID: 22859060
[TBL] [Abstract][Full Text] [Related]
24. Unlocking the Potential of Purinergic Signaling in Transplantation.
Zeiser R; Robson SC; Vaikunthanathan T; Dworak M; Burnstock G
Am J Transplant; 2016 Oct; 16(10):2781-2794. PubMed ID: 27005321
[TBL] [Abstract][Full Text] [Related]
25. Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities.
Wang P; Jia J; Zhang D
JHEP Rep; 2020 Dec; 2(6):100165. PubMed ID: 33103092
[TBL] [Abstract][Full Text] [Related]
26. EVALUATION OF COMPONENTS OF THE EXTRACELLULAR PURINERGIC SIGNALING SYSTEM IN HUMAN SEPSIS.
Lovászi M; Németh ZH; Kelestemur T; Sánchez IV; Antonioli L; Pacher P; Wagener G; Haskó G
Shock; 2024 Apr; 61(4):527-540. PubMed ID: 37752081
[TBL] [Abstract][Full Text] [Related]
27. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC
Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261
[TBL] [Abstract][Full Text] [Related]
28. The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation.
Roberts V; Stagg J; Dwyer KM
Front Immunol; 2014; 5():64. PubMed ID: 24600452
[TBL] [Abstract][Full Text] [Related]
29. Purine Release, Metabolism, and Signaling in the Inflammatory Response.
Linden J; Koch-Nolte F; Dahl G
Annu Rev Immunol; 2019 Apr; 37():325-347. PubMed ID: 30676821
[TBL] [Abstract][Full Text] [Related]
30. Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis.
Lu D; Insel PA
Am J Physiol Cell Physiol; 2014 May; 306(9):C779-88. PubMed ID: 24352335
[TBL] [Abstract][Full Text] [Related]
31. Physiologic roles of P2 receptors in leukocytes.
Alberto AVP; Ferreira NCDS; Bonavita AGC; Nihei OK; Farias FP; Bisaggio RDC; Albuquerque C; Savino W; Coutinho-Silva R; Persechini PM; Alves LA
J Leukoc Biol; 2022 Nov; 112(5):983-1012. PubMed ID: 35837975
[TBL] [Abstract][Full Text] [Related]
32. Purinergic signaling as a new mechanism underlying physical exercise benefits: a narrative review.
Cardoso AM; Silvério MNO; de Oliveira Maciel SFV
Purinergic Signal; 2021 Dec; 17(4):649-679. PubMed ID: 34590239
[TBL] [Abstract][Full Text] [Related]
33. Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation.
Cauwenberghs S; Feijge MA; Hageman G; Hoylaerts M; Akkerman JW; Curvers J; Heemskerk JW
Transfusion; 2006 Jun; 46(6):1018-28. PubMed ID: 16734820
[TBL] [Abstract][Full Text] [Related]
34. Purinergic signaling on leukocytes infiltrating the LPS-injured lung.
Friebe D; Yang T; Schmidt T; Borg N; Steckel B; Ding Z; Schrader J
PLoS One; 2014; 9(4):e95382. PubMed ID: 24748324
[TBL] [Abstract][Full Text] [Related]
35. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
36. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
37. Eosinophils and Purinergic Signaling in Health and Disease.
Ferrari D; Vuerich M; Casciano F; Longhi MS; Melloni E; Secchiero P; Zech A; Robson SC; Müller T; Idzko M
Front Immunol; 2020; 11():1339. PubMed ID: 32733449
[TBL] [Abstract][Full Text] [Related]
38. CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in mice.
Yoshida O; Kimura S; Jackson EK; Robson SC; Geller DA; Murase N; Thomson AW
Hepatology; 2013 Dec; 58(6):2163-75. PubMed ID: 23813862
[TBL] [Abstract][Full Text] [Related]
39. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
Bao X; Xie L
J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
[TBL] [Abstract][Full Text] [Related]
40. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
